Derrick Kretli-Souza, Nathalia Elizabete Paulino, Raiane Aparecida Asevedo, Sara Cristina Leonel Lemos, Gabriel Meireles-Oliveira, Yuri Alves-Silva, Ingrid Rodrigues Hortêncio-Medeiros, Candido Celso Coimbra, Rodrigo Antonio Peliciari-Garcia, Lucas Rios Drummond, Helton Oliveira Campos, Paula Bargi-Souza
{"title":"甲状腺功能减退严重程度的身体成分变化——一项系统回顾和荟萃分析。","authors":"Derrick Kretli-Souza, Nathalia Elizabete Paulino, Raiane Aparecida Asevedo, Sara Cristina Leonel Lemos, Gabriel Meireles-Oliveira, Yuri Alves-Silva, Ingrid Rodrigues Hortêncio-Medeiros, Candido Celso Coimbra, Rodrigo Antonio Peliciari-Garcia, Lucas Rios Drummond, Helton Oliveira Campos, Paula Bargi-Souza","doi":"10.1007/s11154-025-09988-z","DOIUrl":null,"url":null,"abstract":"<p><p>This systematic review and meta-analysis aimed to investigate the impact of clinical hypothyroidism (CH) and subclinical hypothyroidism (SCH) on anthropometric parameters, such as body mass index (BMI), body weight (BW), waist circumference (WC), Hip Circumference (HC), Waist Circumference (WC) and Waist-Hip ratio (W/H). Databases including PubMed, Web of Science, Scopus, and EMBASE were searched for observational studies on hypothyroidism and body composition. The review included 38 studies (54 comparison groups, 49,427 individuals). Effect sizes (ES) with 95% confidence intervals (CI) were used to measure the effects of CH and SCH on body composition compared to healthy controls and between themselves. Effect sizes were defined as negligible (< 0.2), small (0.20-0.49), moderate (0.50-0.79), and large (> 0.8). CH showed large increases in BMI (ES = 1.092; CI: 0.755, 1.429) and BW (ES = 0.897; CI: 0.404, 1.389), and moderate increases in WC (ES = 0.759; CI: 0.419, 1.099) and fat mass (ES = 0.609; CI: 0.051, 1.167). SCH showed moderate increases in BMI (ES = 0.596; CI: 0.403, 0.789) and BW (ES = 0.712; CI: 0.287, 1.138), a small increase in WC (ES = 0.298; CI: 0.141, 0.454), with negligible fat mass changes (ES=-0.055; CI: - 0.760, 0.649). Analysis of SCH by thyroid-stimulating hormone (TSH) levels revealed greater impacts on body composition with increasing TSH. In turn, BMI (ES=-0.082; CI: - 0.577, 0.413) and BW (ES = 0.054; CI: - 0.441, 0.550) showed no significant changes at near-normal TSH (4.0-4.9 mIU/L). Moderate TSH elevation (5.0-10.0 mIU/L) led to moderate increases in BMI (ES = 0.584; CI: 0.343, 0.825) and BW (ES = 0.659; CI: 0.245, 1.073), with a small WC increase (ES = 0.271; CI: 0.077,0.465). TSH > 10.0 mIU/L resulted in large increases in BMI (ES = 1.426; CI: 0.614, 2.238) and BW (ES = 1.942; CI: 1.550, 2.334), along with a small WC increase (ES = 0.271; CI: 0.077, 0.465). The comparison regarding BMI, WC and BW showed no differences between CH and SCH. Both CH and SCH are associated with changes in body composition, mainly BMI, WC, and BW, which may contribute to metabolic risk. Body composition worsens in SCH as TSH levels rise, and stronger effects are evidenced in females and symptomatic individuals.</p>","PeriodicalId":21106,"journal":{"name":"Reviews in Endocrine & Metabolic Disorders","volume":" ","pages":""},"PeriodicalIF":8.0000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Body composition changes across a spectrum of hypothyroidism severity - a systematic review and meta-analysis.\",\"authors\":\"Derrick Kretli-Souza, Nathalia Elizabete Paulino, Raiane Aparecida Asevedo, Sara Cristina Leonel Lemos, Gabriel Meireles-Oliveira, Yuri Alves-Silva, Ingrid Rodrigues Hortêncio-Medeiros, Candido Celso Coimbra, Rodrigo Antonio Peliciari-Garcia, Lucas Rios Drummond, Helton Oliveira Campos, Paula Bargi-Souza\",\"doi\":\"10.1007/s11154-025-09988-z\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This systematic review and meta-analysis aimed to investigate the impact of clinical hypothyroidism (CH) and subclinical hypothyroidism (SCH) on anthropometric parameters, such as body mass index (BMI), body weight (BW), waist circumference (WC), Hip Circumference (HC), Waist Circumference (WC) and Waist-Hip ratio (W/H). Databases including PubMed, Web of Science, Scopus, and EMBASE were searched for observational studies on hypothyroidism and body composition. The review included 38 studies (54 comparison groups, 49,427 individuals). Effect sizes (ES) with 95% confidence intervals (CI) were used to measure the effects of CH and SCH on body composition compared to healthy controls and between themselves. Effect sizes were defined as negligible (< 0.2), small (0.20-0.49), moderate (0.50-0.79), and large (> 0.8). CH showed large increases in BMI (ES = 1.092; CI: 0.755, 1.429) and BW (ES = 0.897; CI: 0.404, 1.389), and moderate increases in WC (ES = 0.759; CI: 0.419, 1.099) and fat mass (ES = 0.609; CI: 0.051, 1.167). SCH showed moderate increases in BMI (ES = 0.596; CI: 0.403, 0.789) and BW (ES = 0.712; CI: 0.287, 1.138), a small increase in WC (ES = 0.298; CI: 0.141, 0.454), with negligible fat mass changes (ES=-0.055; CI: - 0.760, 0.649). Analysis of SCH by thyroid-stimulating hormone (TSH) levels revealed greater impacts on body composition with increasing TSH. In turn, BMI (ES=-0.082; CI: - 0.577, 0.413) and BW (ES = 0.054; CI: - 0.441, 0.550) showed no significant changes at near-normal TSH (4.0-4.9 mIU/L). Moderate TSH elevation (5.0-10.0 mIU/L) led to moderate increases in BMI (ES = 0.584; CI: 0.343, 0.825) and BW (ES = 0.659; CI: 0.245, 1.073), with a small WC increase (ES = 0.271; CI: 0.077,0.465). TSH > 10.0 mIU/L resulted in large increases in BMI (ES = 1.426; CI: 0.614, 2.238) and BW (ES = 1.942; CI: 1.550, 2.334), along with a small WC increase (ES = 0.271; CI: 0.077, 0.465). The comparison regarding BMI, WC and BW showed no differences between CH and SCH. Both CH and SCH are associated with changes in body composition, mainly BMI, WC, and BW, which may contribute to metabolic risk. Body composition worsens in SCH as TSH levels rise, and stronger effects are evidenced in females and symptomatic individuals.</p>\",\"PeriodicalId\":21106,\"journal\":{\"name\":\"Reviews in Endocrine & Metabolic Disorders\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":8.0000,\"publicationDate\":\"2025-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reviews in Endocrine & Metabolic Disorders\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s11154-025-09988-z\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reviews in Endocrine & Metabolic Disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11154-025-09988-z","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
Body composition changes across a spectrum of hypothyroidism severity - a systematic review and meta-analysis.
This systematic review and meta-analysis aimed to investigate the impact of clinical hypothyroidism (CH) and subclinical hypothyroidism (SCH) on anthropometric parameters, such as body mass index (BMI), body weight (BW), waist circumference (WC), Hip Circumference (HC), Waist Circumference (WC) and Waist-Hip ratio (W/H). Databases including PubMed, Web of Science, Scopus, and EMBASE were searched for observational studies on hypothyroidism and body composition. The review included 38 studies (54 comparison groups, 49,427 individuals). Effect sizes (ES) with 95% confidence intervals (CI) were used to measure the effects of CH and SCH on body composition compared to healthy controls and between themselves. Effect sizes were defined as negligible (< 0.2), small (0.20-0.49), moderate (0.50-0.79), and large (> 0.8). CH showed large increases in BMI (ES = 1.092; CI: 0.755, 1.429) and BW (ES = 0.897; CI: 0.404, 1.389), and moderate increases in WC (ES = 0.759; CI: 0.419, 1.099) and fat mass (ES = 0.609; CI: 0.051, 1.167). SCH showed moderate increases in BMI (ES = 0.596; CI: 0.403, 0.789) and BW (ES = 0.712; CI: 0.287, 1.138), a small increase in WC (ES = 0.298; CI: 0.141, 0.454), with negligible fat mass changes (ES=-0.055; CI: - 0.760, 0.649). Analysis of SCH by thyroid-stimulating hormone (TSH) levels revealed greater impacts on body composition with increasing TSH. In turn, BMI (ES=-0.082; CI: - 0.577, 0.413) and BW (ES = 0.054; CI: - 0.441, 0.550) showed no significant changes at near-normal TSH (4.0-4.9 mIU/L). Moderate TSH elevation (5.0-10.0 mIU/L) led to moderate increases in BMI (ES = 0.584; CI: 0.343, 0.825) and BW (ES = 0.659; CI: 0.245, 1.073), with a small WC increase (ES = 0.271; CI: 0.077,0.465). TSH > 10.0 mIU/L resulted in large increases in BMI (ES = 1.426; CI: 0.614, 2.238) and BW (ES = 1.942; CI: 1.550, 2.334), along with a small WC increase (ES = 0.271; CI: 0.077, 0.465). The comparison regarding BMI, WC and BW showed no differences between CH and SCH. Both CH and SCH are associated with changes in body composition, mainly BMI, WC, and BW, which may contribute to metabolic risk. Body composition worsens in SCH as TSH levels rise, and stronger effects are evidenced in females and symptomatic individuals.
期刊介绍:
Reviews in Endocrine and Metabolic Disorders is an international journal dedicated to the field of endocrinology and metabolism. It aims to provide the latest advancements in this rapidly advancing field to students, clinicians, and researchers. Unlike other journals, each quarterly issue of this review journal focuses on a specific topic and features ten to twelve articles written by world leaders in the field. These articles provide brief overviews of the latest developments, offering insights into both the basic aspects of the disease and its clinical implications. This format allows individuals in all areas of the field, including students, academic clinicians, and practicing clinicians, to understand the disease process and apply their knowledge to their specific areas of interest. The journal also includes selected readings and other essential references to encourage further in-depth exploration of specific topics.